Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export

Lei, Peng, Ayton, Scott, Finkelstein, David I, Spoerri, Loredana, Ciccotosto, Giuseppe D, Wright, David K, Wong, Bruce X W, Adlard, Paul A +9 more·2012·Nature Medicine

Cited by (596)

Items 201–300 of 596

  1. Metal Chelation Therapy and Parkinson’s Disease: A Critical Review on the Thermodynamics of Complex Formation between Relevant Metal Ions and Promising or Established Drugs
    Marianna Tosato, Valerio Di Marco · 2019 · Biomolecules
  2. Tau regulates the localization and function of End‐binding proteins 1 and 3 in developing neuronal cells
    Carmen Laura Sayas, Elena Tortosa, Flavia Andrea Bollati, Sacnicte Ramírez‐Ríos, Isabelle Arnal, Jesús Ávila · 2015 · Journal of Neurochemistry
  3. Iron Chelation Nanoparticles with Delayed Saturation as an Effective Therapy for Parkinson Disease
    Nan Wang, Xin Jin, Dongbo Guo, Gangsheng Tong, Xinyuan Zhu · 2016 · Biomacromolecules
  4. The Potential Role of Ferroptosis in Alzheimer’s Disease
    Guimei Zhang, Ya-Ru Zhang, Yanxin Shen, Yongchun Wang, Meng Liang Zhao, Li Sun · 2021 · Journal of Alzheimer s Disease
  5. Driving factors of neuronal ferroptosis
    Julie Jacquemyn, Isha Ralhan, Maria S. Ioannou · 2024 · Trends in Cell Biology
  6. Neuroferroptosis in health and diseases
    Peng Lei, Tara L. Walker, Scott Ayton · 2025 · Nature reviews. Neuroscience
  7. The Neuronal Tau Protein Blocks in Vitro Fibrillation of the Amyloid-β (Aβ) Peptide at the Oligomeric Stage
    Cecilia Wallin, Yoshitaka Hiruma, Sebastian K.T.S. Wärmländer, Isabelle Huvent, Jüri Jarvet, Jan Pieter Abrahams, Astrid Gräslund, Guy M. Lippens, Jinghui Luo · 2018 · Journal of the American Chemical Society
  8. Caenorhabditis elegans: a model to investigate oxidative stress and metal dyshomeostasis in Parkinson's disease
    Patricia Mugure Chege, Gawain McColl · 2014 · Frontiers in Aging Neuroscience
  9. Cdk5 at crossroads of protein oligomerization in neurodegenerative diseases: facts and hypotheses
    Anna Wilkaniec, Grzegorz Arkadiusz Czapski, Agata Adamczyk · 2015 · Journal of Neurochemistry
  10. Amyloid β-interacting partners in Alzheimer's disease: From accomplices to possible therapeutic targets
    Han, Sun-Ho, Park, Jong-Chan, Mook-Jung, Inhee · 2016 · Progress in Neurobiology
  11. Iron dyshomeostasis and ferroptosis in Alzheimer’s disease: Molecular mechanisms of cell death and novel therapeutic drugs and targets for AD
    Yuan Zhang, Man Wang, Wenguang Chang · 2022 · Frontiers in Pharmacology
  12. Role of ferroptosis pathways in neuroinflammation and neurological disorders: From pathogenesis to treatment
    Syam Mohan, Hassan A. Alhazmi, Rym Hassani, Gulrana Khuwaja, V. P. Maheshkumar, Afaf Ahmed Aldahish, Kumarappan Chidambaram · 2024 · Heliyon
  13. A review on iron chelators as potential therapeutic agents for the treatment of Alzheimer’s and Parkinson’s diseases
    Yash Pal Singh, Amruta Pandey, Swati Vishwakarma, Gyan Prakash Modi · 2018 · Molecular Diversity
  14. Iron metabolism mediates microglia susceptibility in ferroptosis
    Lingling Jiao, Xiaolan Li, Yuxiang Luo, Junfen Wei, Xulong Ding, Huan Xiong, Xuesong Liu, Peng Lei · 2022 · Frontiers in Cellular Neuroscience
  15. Tau is required for glial lipid droplet formation and resistance to neuronal oxidative stress
    Lindsey D. Goodman, Isha Ralhan, Xin Li, Shenzhao Lu, Matthew J. Moulton, Ye-Jin Park, Pinghan Zhao, Oguz Kanca, Ziyaneh S. Ghaderpour Taleghani, Julie Jacquemyn et al. · 2024 · Nature Neuroscience
  16. Hepcidin and its therapeutic potential in neurodegenerative disorders
    Zhong‐Ming Qian, Ya Ke · 2019 · Medicinal Research Reviews
  17. Iron Pathophysiology in Alzheimer’s Diseases
    Wang, Tao, Xu, Shuang-Feng, Fan, Yong-Gang, Li, Lin-Bo, Guo, Chuang · 2019 · Advances in experimental medicine and biology
  18. Postmortem T 2 * - Weighted MRI Imaging of Cortical Iron Reflects Severity of Alzheimer’s Disease
    Marjolein Bulk, Boyd Kenkhuis, Linda M. van der Graaf, Jelle J. Goeman, Remco Natté, Louise van der Weerd · 2018 · Journal of Alzheimer s Disease
  19. Iron chelation and multiple sclerosis
    Weigel, Kelsey J., Lynch, Sharon G., LeVine, Steven M. · 2014 · ASN NEURO
  20. Direct modulation of microtubule stability contributes to anthracene general anesthesia
    Emerson, Daniel J., Weiser, Brian P., Psonis, John, Liao, Zhengzheng, Taratula, Olena, Fiamengo, Ashley, Wang, Xiaozhao, Sugasawa, Keizo, Smith, Amos B., Eckenhoff, Roderic G. et al. · 2013 · Journal of the American Chemical Society
  21. Enduring Elevations of Hippocampal Amyloid Precursor Protein and Iron Are Features of β-Amyloid Toxicity and Are Mediated by Tau
    Xuling Li, Peng Lei, Qing‐zhang Tuo, Scott Ayton, Qiao‐Xin Li, Steve Moon, Irene Volitakis, Rong Liu, Colin Louis Masters, David Isaac Finkelstein et al. · 2015 · Neurotherapeutics
  22. The ordered assembly of tau is the gain‐of‐toxic function that causes human tauopathies
    Michel Goedert · 2016 · Alzheimer s & Dementia
  23. Hydrophobic tagging-mediated degradation of Alzheimer's disease related Tau
    Gao, Na, Chu, Ting-Ting, Li, Qian-Qian, Lim, Yeh-Jun, Qiu, Tian, Ma, Meng-Rong, Hu, Zhi-Wen, Yang, Xi-Fei, Chen, Yong-Xiang, Zhao, Yu-Fen et al. · 2017 · RSC Advances
  24. Passive immunotherapy for Alzheimer's disease
    Xiaoyi Guo, Yan Li, Denghong Zhang, Yingjun Zhao · 2024 · Ageing Research Reviews
  25. Nexus between mitochondrial function, iron, copper and glutathione in Parkinson's disease
    Jeffrey R. Liddell, Anthony Robert White · 2017 · Neurochemistry International
  26. Parkinsonism and Related Disorders
    Elizabeth Slow, Anthony Edward Lang · 2019 · DeckerMed Transitional Year Weekly Curriculum™
  27. A brief history of brain iron accumulation in Parkinson disease and related disorders
    Paul Bernard Foley, Dominic James Hare, Kay L. Double · 2022 · Journal of Neural Transmission
  28. Dysregulation of Neuronal Iron Homeostasis as an Alternative Unifying Effect of Mutations Causing Familial Alzheimer’s Disease
    Amanda L. Lumsden, Jack T. Rogers, Shohreh Majd, Morgan Newman, Greg Trevor Sutherland, Giuseppe Verdile, Michael T. Lardelli · 2018 · Frontiers in Neuroscience
  29. Ultrasensitive assays for detection of plasma tau and phosphorylated tau 181 in Alzheimer’s disease: a systematic review and meta-analysis
    Xulong Ding, Shuting Zhang, Lijun Jiang, Lu Wang, Tao Li, Peng Lei · 2021 · Translational Neurodegeneration
  30. Chronic arsenic exposure induces ferroptosis via enhancing ferritinophagy in chicken livers
    Lu Yu, Zhanjun Lv, Siyu Li, Huijie Jiang, Biqi Han, Xiaoyan Zheng, Yunfeng Liu, Zhigang Zhang · 2023 · The Science of The Total Environment
  31. Metal chaperones prevent zinc-mediated cognitive decline
    Paul Anthony Adlard, Jacqui M. Parncutt, Varsha Lal, Simon James, Dominic James Hare, Philip Doble, David Isaac Finkelstein, Ashley Ian Bush · 2014 · Neurobiology of Disease
  32. Mutations in the Microtubule-Associated Protein 1A ( Map1a ) Gene Cause Purkinje Cell Degeneration
    Ye Liu, Jeong-Woong Lee, Susan L. Ackerman · 2015 · Journal of Neuroscience
  33. Designing drugs with multi-target activity: the next step in the treatment of neurodegenerative disorders
    Werner J. Geldenhuys, Cornelis J. Van der Schyf · 2012 · Expert Opinion on Drug Discovery
  34. ADSC Therapy in Neurodegenerative Disorders
    Tzu-Min Chan, Julia Yi-Ru Chen, Li-Ing Ho, Hui-Ping Lin, Kuo-Wei Hsueh, Demeral David Liu, Yi-Hung Chen, An-Cheng Hsieh, Nu‐Man Tsai, Dueng‐Yuan Hueng et al. · 2014 · Cell Transplantation
  35. Perturbed iron biology in the prefrontal cortex of people with schizophrenia
    Amit Lotan, Sandra Luza, Carlos Opazo, Scott Ayton, Darius J.R. Lane, Serafino G. Mancuso, Avril M. Pereira, Suresh Sundram, Cynthia Shannon Weickert, Chad Bousman et al. · 2023 · Molecular Psychiatry
  36. Antioxidant, anti‐inflammatory and epigenetic potential of curcumin in Alzheimer's disease
    Toufik Abdul‐Rahman, Wireko Andrew Awuah, Tatiana Mikhailova, Jacob B. Kalmanovich, Aashna Mehta, Jyi Cheng Ng, Megan Ariel Coghlan, Marija Zivcevska, Alexander J. Tedeschi, Emerson Costa Oliveira et al. · 2024 · BioFactors
  37. Ceruloplasmin and β-amyloid precursor protein confer neuroprotection in traumatic brain injury and lower neuronal iron
    Scott Ayton, Moses Zhang, Blaine Russell Roberts, Linh Q. Lam, Monica Lind, Catriona McLean, Ashley Ian Bush, Tony Frugier, Peter John Crack, James A. Duce · 2014 · Free Radical Biology and Medicine
  38. Ferroptosis Is Regulated by Mitochondria in Neurodegenerative Diseases
    Jue-Pu Zhou, Yao Jin, Yu-Hong Lei, Tianyi Liu, Zheng Wan, Hao Meng, Honglei Wang · 2020 · Neurodegenerative Diseases
  39. RETRACTED: Decrypting the potential role of α-lipoic acid in Alzheimer's disease
    Dapinder Kaur, Tapan Behl, Aayush Sehgal, Sukhbir Singh, Neelam Sharma, Sridevi Chigurupati, Ahmed Alhowail, Ahmed Abdeen, Samah Fathy Ibrahim, Celia Bertha Vargas-De-La-Cruz et al. · 2021 · Life Sciences · Retracted
  40. Cortical phase changes in Alzheimer's disease at 7T MRI: A novel imaging marker
    Sanneke van Rooden, Maarten J. Versluis, Michael K. Liem, Julien Milles, Andrea Britta Maier, Ania M. Oleksik, ANDREW G. WEBB, Mark A. van Buchem, Jeroen van der Grond · 2013 · Alzheimer s & Dementia
  41. Iron overload causes endolysosomal deficits modulated by NAADP-regulated 2-pore channels and RAB7A
    Belén Fernández, Elena Fdez, Patricia Gómez‐Suaga, Fernando Gil, Isabel Molina-Villalba, Isidró Ferrer, Sandip Patel, Grant C. Churchill, Sabine Hilfiker · 2016 · Autophagy
  42. Rare variants in β-Amyloid precursor protein (APP) and Parkinson’s disease
    Eva Christina Schulte, Akio Fukumori, Brit Mollenhauer, Hyun Hor, Thomas Arzberger, Robert Perneczky, Alexander Kurz, Janine Diehl‐Schmid, Michael Hüll, Peter Lichtner et al. · 2015 · European Journal of Human Genetics
  43. Genetics and iron in the systems biology of Parkinson’s disease and some related disorders
    Claudia Funke, Susanne A. Schneider, Daniela Berg, Douglas Bruce Kell · 2012 · Neurochemistry International
  44. Brain regions susceptible to alpha-synuclein spreading
    Yujie Guo, Huan Xiong, Kang Chen, Jin-Jun Zou, Peng Lei · 2021 · Molecular Psychiatry
  45. Inhibition of ACSL4 Alleviates Parkinsonism Phenotypes by Reduction of Lipid Reactive Oxygen Species
    Fei Tang, Liu-yao Zhou, Ping Li, Lingling Jiao, Kang Chen, Yujie Guo, Xulong Ding, Siyu He, Biao Dong, Ruxiang Xu et al. · 2023 · Neurotherapeutics
  46. Alzheimer’s disease and related tauopathies: disorders of disrupted neuronal identity
    Bess E Frost · 2023 · Trends in Neurosciences
  47. Untangling the Tauopathy for Alzheimer’s disease and parkinsonism
    Hui-Yun Chang, Tzu‐Kang Sang, Ann‐Shyn Chiang · 2018 · Journal of Biomedical Science
  48. Formaldehyde induces ferroptosis in hippocampal neuronal cells by upregulation of the Warburg effect
    Xiaona Li, San‐Qiao Yang, Min Li, Xuesong Li, Qing Tian, Fan Xiao, Yi-Yun Tang, Xuan Kang, Chunyan Wang, Wei Zou et al. · 2020 · Toxicology
  49. Dopaminergic dysfunction in the 3xTg-AD mice model of Alzheimer’s disease
    Yesica Gloria, Kelly Ceyzériat, Stergios Tsartsalis, P. Millet, Benjamin B. Tournier · 2021 · Scientific Reports
  50. A novel approach to rapidly prevent age‐related cognitive decline
    Paul Anthony Adlard, Amelia Sedjahtera, Lydia Gunawan, Lisa Bray, Dominic James Hare, Jessica Lear, Philip Doble, Ashley Ian Bush, David Isaac Finkelstein, Robert A. Cherny · 2013 · Aging Cell
  51. Digital and Analog Chemical Evolution
    Jay T. Goodwin, Anil K. Mehta, David G. Lynn · 2012 · Accounts of Chemical Research
  52. Caspase-cleaved tau is senescence-associated and induces a toxic gain of function by putting a brake on axonal transport
    Christian Conze, Marina Rierola, Nataliya I. Trushina, Michael Peters, Dennis Janning, Max Holzer, Jürgen J. Heinisch, Thomas Arendt, Lidia Bakota, Roland Brandt · 2022 · Molecular Psychiatry
  53. Insight into the potential role of ferroptosis in neurodegenerative diseases
    Yingying Ji, Kai Zheng, Shiming Li, Caili Ren, Ying Shen, Lin Tian, Haohao Zhu, Zhenhe Zhou, Ying Jiang · 2022 · Frontiers in Cellular Neuroscience
  54. Overexpression of Heme Oxygenase 1 Causes Cognitive Decline and Affects Pathways for Tauopathy in Mice
    Dayong Wang, Yang Hui, Yahui Peng, Lu Tang, Jianfeng Jin, Rongzhang He, Yanze Li, Shuai Zhang, Lisha Li, You Lang Zhou et al. · 2014 · Journal of Alzheimer s Disease
  55. Modulation of iron metabolism in aging and in Alzheimer's disease: relevance of the choroid plexus
    Sandro Dá Mesquita, Ana Catarina Ferreira, João Carlos Sousa, Nadine Correia Santos, Margarida Correia‐Neves, Nuno Sousa, Joana Almeida Palha, Fernanda Marques · 2012 · Frontiers in Cellular Neuroscience
  56. Behavioral Abnormalities in Knockout and Humanized Tau Mice
    Rafaella Araujo Gonçalves, Nadeeja Wijesekara, Paul E. Fraser, Fernanda G. De Felice · 2020 · Frontiers in Endocrinology
  57. Overdosing on iron: Elevated iron and degenerative brain disorders
    Santosh R. D’Mello, Mark S. Kindy · 2020 · Experimental Biology and Medicine
  58. The iron regulatory capability of the major protein participants in prevalent neurodegenerative disorders
    Bruce X. W. Wong, James A. Duce · 2014 · Frontiers in Pharmacology
  59. Identification of a LargeDNAJB2Deletion in a Family with Spinal Muscular Atrophy and Parkinsonism
    Elena Sánchez, Hossein Darvish, Roxana Mesias, Shaghyegh Taghavi, Saghar Ghasemi Firouzabadi, Ruth Helen Walker, Abbas Tafakhori, Coro Paisán‐Ruiz · 2016 · Human Mutation
  60. A Comprehensive Phenotype of Non-motor Impairments and Distribution of Alpha-Synuclein Deposition in Parkinsonism-Induced Mice by a Combination Injection of MPTP and Probenecid
    Na‐Ra Han, Yu-Kang Kim, Sora Ahn, Tae‐Yeon Hwang, Hyejung Lee, Hi‐Joon Park · 2021 · Frontiers in Aging Neuroscience
  61. The Role of Iron Metabolism, Lipid Metabolism, and Redox Homeostasis in Alzheimer’s Disease: from the Perspective of Ferroptosis
    Linyu Wu, Xiao‐Hui Xian, Zixuan Tan, Fang Dong, Guangyu Xu, Min Zhang, Feng Zhang · 2023 · Molecular Neurobiology
  62. Triggering ferroptosis in neurodegenerative diseases
    Triet Phu Minh Nguyen, Francesca M. Alves, Darius J.R. Lane, Ashley Ian Bush, Scott Ayton · 2025 · Trends in Neurosciences
  63. Ferroptosis as a New Mechanism in Parkinson’s Disease Therapy Using Traditional Chinese Medicine
    Lijuan Wu, Meijun Liu, Jingtao Liang, Nannan Li, Dongdong Yang, Junjie Cai, Yong Zhang, Yuan Zhang He, Zhigang Chen, Tao Ma · 2021 · Frontiers in Pharmacology
  64. Loss of tau results in defects in photoreceptor development and progressive neuronal degeneration in Drosophila
    Bonnie J. Bolkan, Doris Kretzschmar · 2014 · Developmental Neurobiology
  65. A role for amyloid precursor protein translation to restore iron homeostasis and ameliorate lead (Pb) neurotoxicity
    Jack T. Rogers, Vivek Venkataramani, Cecilia Washburn, Yanyan Liu, Vinusha Tummala, Hong Fu Jiang, Ann Smith, Catherine M. Cahill · 2016 · Journal of Neurochemistry
  66. Challenges and Opportunities of Metal Chelation Therapy in Trace Metals Overload-Induced Alzheimer’s Disease
    Vinay Chaudhari, Siddhi Bagwe‐Parab, Harpal Singh Buttar, Shubhangi Gupta, Amisha Vora, Ginpreet Kaur · 2023 · Neurotoxicity Research
  67. Deletion of endogenous Tau proteins is not detrimental in Drosophila
    Sylvie Burnouf, Sebastian Grönke, Hrvoje Augustin, Jacqueline Dols, Marianna Karina Gorsky, Jennifer Annette Werner, Fiona Kerr, Nazif Alic, Pedro Martinez, Linda Partridge · 2016 · Scientific Reports
  68. The Ferroxidase Hephaestin But Not Amyloid Precursor Protein is Required for Ferroportin-Supported Iron Efflux in Primary Hippocampal Neurons
    Changyi Ji, Brittany L. Steimle, Danielle K. Bailey, Daniel J. Kosman · 2017 · Cellular and Molecular Neurobiology
  69. Iron Dysregulation in Parkinson’s Disease: Focused on the Autophagy–Lysosome Pathway
    Leilei Chen, Yujv Huang, Juntao Cui, Ning Song, Junxia Xie · 2018 · ACS Chemical Neuroscience
  70. Targeting the Iron-Response Elements of the mRNAs for the Alzheimer’s Amyloid Precursor Protein and Ferritin to Treat Acute Lead and Manganese Neurotoxicity
    Jack T. Rogers, Ning Xia, Angela Y. Wong, Rachit Bakshi, Catherine M. Cahill · 2019 · International Journal of Molecular Sciences
  71. The Cytoskeleton as a Modulator of Aging and Neurodegeneration
    Konstantinos Kounakis, Nektarios Tavernarakis · 2019 · Advances in experimental medicine and biology
  72. The Case for an Estrogen-iron Axis in Health and Disease
    Mawieh A. Hamad, Khuloud Bajbouj, Jalal Taneera · 2019 · Experimental and Clinical Endocrinology & Diabetes
  73. Iron in Alzheimer’s Disease: From Physiology to Disease Disabilities
    Amit Pal, Giselle Cerchiaro, Isha Rani, Mariacarla Ventriglia, Mauro Ciro Antonio Rongioletti, Antonio Longobardi, Rosanna Squitti · 2022 · Biomolecules
  74. Research progress in the molecular mechanism of ferroptosis in Parkinson's disease and regulation by natural plant products
    Kailin Yang, Liuting Zeng, Jinsong Zeng, Ying Deng, Shanshan Wang, Hao Xu, Qi He, Mengxia Yuan, Yanfang Luo, Anqi Ge et al. · 2023 · Ageing Research Reviews
  75. The secret life of extracellular vesicles in metal homeostasis and neurodegeneration
    Shayne A. Bellingham, Belinda B. Guo, Andrew Francis Hill · 2015 · Biology of the Cell
  76. Potential role and therapeutic implications of glutathione peroxidase 4 in the treatment of Alzheimer’s disease
    Yanxin Shen, Guimei Zhang, Chunxiao Wei, Panpan Zhao, Yongchun Wang, Mingxi Li, Li Sun · 2024 · Neural Regeneration Research
  77. Pre-treatment of rats with ad-hepcidin prevents iron-induced oxidative stress in the brain
    Jing Gong, Fang Du, Zhong‐Ming Qian, Qian Qian Luo, Yuan Sheng, Wing‐Ho Yung, Yan Xin Xu, Ya Ke · 2015 · Free Radical Biology and Medicine
  78. Generation of a New Tau Knockout (tau Δex1 ) Line Using CRISPR/Cas9 Genome Editing in Mice
    Daniel C. S. Tan, Sherilyn Yao, Arne Ittner, Josefine Bertz, Yazi Diana Ke, Lars Matthias Ittner, Fabien Delerue · 2018 · Journal of Alzheimer s Disease
  79. Alpha-synuclein inhibits Snx3–retromer-mediated retrograde recycling of iron transporters in S. cerevisiae and C. elegans models of Parkinson’s disease
    Dhaval Patel, Chuan Xu, Sureshbabu Nagarajan, Zhengchang Liu, Wayne O. Hemphill, Runhua Shi, Vladimir Nikolaevich Uversky, Guy A. Caldwell, Kim A. Caldwell, Stephan N. Witt · 2018 · Human Molecular Genetics
  80. Iron promotes both ferroptosis and necroptosis in the early stage of reperfusion in ischemic stroke
    Bin Du, Zijie Deng, Kang Chen, Zhangzhong Yang, Junfen Wei, Liuyao Zhou, Jie Meng, Ying Cheng, Xin Tian, Qing‐zhang Tuo et al. · 2024 · Genes & Diseases
  81. Transferrin protects against Parkinsonian neurotoxicity and is deficient in Parkinson’s substantia nigra
    Scott Ayton, Peng Lei, Catriona McLean, Ashley Ian Bush, David Isaac Finkelstein · 2016 · Signal Transduction and Targeted Therapy
  82. Early-Life Environment Influence on Late-Onset Alzheimer’s Disease
    Thibaut Gauvrit, Hamza Benderradji, Luc Buée, David L Blum, Didier Vieau · 2022 · Frontiers in Cell and Developmental Biology
  83. Mitochondrial ferritin suppresses MPTP-induced cell damage by regulating iron metabolism and attenuating oxidative stress
    Linhao You, Zhen Li, Xianglin Duan, Baolu Zhao, Yan‐Zhong Chang, Zhenhua Shi · 2016 · Brain Research
  84. Chaperone-dependent Neurodegeneration: A Molecular Perspective on Therapeutic Intervention
    Aaron Carman Sarah Kishinevsky, John Koren III Wenjie Lou · 2013 · Journal of Alzheimer’s Disease & Parkinsonism
  85. Ferroptosis promotes microtubule-associated protein tau aggregation via GSK-3β activation and proteasome inhibition
    Shaohui Wang, Yao Xing Jiang, Yabo Liu, Qianhui Liu, Hongwei Sun, Mengjie Mei, Xiaomei Liao · 2022 · Molecular Neurobiology
  86. Molecular mechanisms and therapeutic potential of lithium in Alzheimer’s disease: repurposing an old class of drugs
    Yanxin Shen, Meng Zhao, Panpan Zhao, Lingjie Meng, Yan Zhang, Guimei Zhang, Yezi Taishi, Li Sun · 2024 · Frontiers in Pharmacology
  87. The close relationship between trace elements (Cu, Fe, Zn, Se, Rb, Si, Cr, and V) and Alzheimer's disease: Research progress and insights
    Yuanhui Mao, Lishuo Zhang, Chengfu Zhang, Linyin Qin, Xiayun Liao, Lichun Zhao · 2025 · Journal of Trace Elements in Medicine and Biology
  88. No Overt Deficits in Aged Tau-Deficient C57Bl/6.Mapttm1(EGFP)Kit GFP Knockin Mice
    Annika van Hummel, Mian Bi, Stefania Ippati, Julia van der Hoven, Alexander M. Volkerling, Wei S. Lee, Daniel C. S. Tan, André Bongers, Arne Ittner, Yazi Diana Ke et al. · 2016 · PLoS ONE
  89. Iron metabolism and its detection through MRI in parkinsonian disorders: a systematic review
    Sara Pietracupa, Antonio Martín‐Bastida, Paola P. Piccini · 2017 · Neurological Sciences
  90. Lactoferrin: from the structure to the functional orchestration of iron homeostasis
    Giusi Ianiro, Luigi Rosa, Maria Carmela Bonaccorsi di Patti, Piera Valenti, Giovanni Musci, Antimo Cutone · 2022 · BioMetals
  91. Iron-responsive-like elements and neurodegenerative ferroptosis
    Jack T. Rogers, Catherine M. Cahill · 2020 · Learning & Memory
  92. Metals and cholesterol: two sides of the same coin in Alzheimer’s disease pathology
    Bruce X. W. Wong, Ya Hui Hung, Ashley Ian Bush, James A. Duce · 2014 · Frontiers in Aging Neuroscience
  93. Absence of Tau triggers age‐dependent sciatic nerve morphofunctional deficits and motor impairment
    Sofia Lopes, André T. Lopes, Vítor Pinto, Marco Rafael Guimarães, Vanessa Morais Sardinha, Sara Duarte‐Silva, Sara Pinheiro, João Pizarro, João Filipe Oliveira, Nuno Sousa et al. · 2016 · Aging Cell
  94. Accelerated kindling epileptogenesis in Tg4510 tau transgenic mice, but not in tau knockout mice
    Shijie Liu, Yu Shen, Sandy R. Shultz, Anne Nguyen, Christopher M. Hovens, Paul Anthony Adlard, Ashley Ian Bush, Jianxiong Chan, Patrick Kwan, Terence John O'Brien et al. · 2017 · Epilepsia
  95. The effect of dopamine on MPTP-induced rotarod disability
    Scott Ayton, Jessica L. George, Paul Anthony Adlard, Ashley Ian Bush, Robert A. Cherny, David Isaac Finkelstein · 2013 · Neuroscience Letters
  96. Interactions Between α-Synuclein and Tau Protein: Implications to Neurodegenerative Disorders
    Xuling Li, Simon James, Peng Lei · 2016 · Journal of Molecular Neuroscience
  97. Emerging Diagnostic and Therapeutic Strategies for Tauopathies
    David G. Coughlin, David John Irwin · 2017 · Current Neurology and Neuroscience Reports
  98. Increased Tau Expression Correlates with Neuronal Maturation in the Developing Human Cerebral Cortex
    Kimberly L. Fiock, Martin E. Smalley, John F. Crary, Anca M. Pașca, Marco M. Hefti · 2020 · eNeuro
  99. Beyond Neuronal Microtubule Stabilization: MAP6 and CRMPS, Two Converging Stories
    Camille Cuveillier, Benoît Boulan, Charlotte Ravanello, Éric Denarier, Jean‐Christophe Deloulme, Sylvie Gory‐Fauré, Christian Delphin, Christophe Bosc, Isabelle Arnal, Annie Andrieux · 2021 · Frontiers in Molecular Neuroscience
  100. Insulin Resistance as a Common Link Between Current Alzheimer’s Disease Hypotheses
    Suélen Santos Alves, Rui Milton Patrício da Silva-Júnior, Gabriel Servilha‐Menezes, Jan Homolak, Melita Šalković‐Petrišić, Norberto Garcia‐Cairasco · 2021 · Journal of Alzheimer s Disease